Key Benefits

• See gout risk and heart health status by measuring uric acid and HDL-C.
• Spot hyperuricemia that raises gout flares and uric acid kidney stone risk.
• Clarify sudden red, swollen joint pain by supporting a gout diagnosis versus other causes.
• Guide uric acid–lowering medicine by treating to serum urate targets (<6 mg/dL; tophi <5).
• Flag low HDL-C that signals higher heart risk, not a drug target.
• Guide prevention intensity alongside LDL-C, triglycerides, blood pressure, diabetes status, and smoking.
• Explain combined patterns that suggest insulin resistance, metabolic syndrome, and kidney strain.
• Track response to lifestyle changes, statins, and urate‑lowering medications over time.

What is an Uric Acid / HDL-C blood test?

Uric Acid / HDL-C blood testing measures two related signals and expresses them together as a ratio. Uric acid (urate) is the end product of purine breakdown, formed mainly in the liver and carried in the bloodstream before most of it is cleared by the kidneys. HDL-C is the cholesterol cargo within high-density lipoproteins, particles made in the liver and intestine that circulate in blood. Putting them together as the uric acid–to–HDL cholesterol ratio (UHR) summarizes these opposing biological currents in one number.

What it reflects: uric acid tends to mirror metabolic and oxidative pressure in the body (oxidative stress, low-grade inflammation, purine turnover), while HDL particles contribute to protective tasks such as cholesterol efflux and reverse cholesterol transport (RCT), along with antioxidant and anti-inflammatory actions at the vessel lining (endothelium). The UHR therefore captures the balance between pro-oxidant, metabolism-linked load and the counterbalancing, vessel-protective capacity of HDL. In practical terms, it offers a compact view of how your system is managing purine metabolism, lipid transport, and redox/inflammatory tone within the circulation.

Why is an Uric Acid / HDL-C blood test important?

The uric acid/HDL-C ratio links two powerful signals of metabolic health: uric acid, the end-product of purine metabolism that shifts from antioxidant to pro-oxidant at higher levels, and HDL cholesterol, which supports reverse cholesterol transport and vascular repair. Together, this ratio reflects the balance between oxidative/inflammatory load and lipid-clearing capacity, touching the heart, kidneys, liver, joints, and blood vessels.

There is no universal clinical reference range for this ratio. In general, lower values are considered more favorable because they pair lower uric acid with higher HDL. Ratios tend to be lower in women (especially premenopausal) and in youth, and often rise with age and central adiposity.

When the ratio is low, it usually means efficient urate handling and robust HDL function. People typically feel well; this pattern aligns with better insulin sensitivity and endothelial health. Exceptionally low values, driven by very low uric acid, are uncommon and can accompany rare renal tubular transport conditions or severe undernutrition, but most individuals are asymptomatic.

Higher ratios usually reflect hyperuricemia and/or low HDL. Physiologically, this aligns with insulin resistance, adipose inflammation, endothelial dysfunction, and hepatic fat accumulation. Clinically, it associates with gout flares, uric acid kidney stones, hypertension, chronic kidney disease, and atherosclerotic risk. Ratios often rise in men, in postmenopausal women, and in teens with obesity; in pregnancy, a rising ratio late in gestation can track with higher uric acid and adverse placental vascular states.

Big picture: this ratio integrates purine metabolism, renal excretion, oxidative stress, and lipoprotein transport. Interpreted alongside uric acid, HDL, triglycerides, glucose, blood pressure, and liver markers, it helps profile long-term cardiometabolic and renal risk.

What insights will I get?

The uric acid/HDL-C ratio divides serum uric acid by HDL cholesterol. It reflects the balance between purine-derived oxidative load and HDL’s cholesterol transport and antioxidant activity, linking to insulin sensitivity, vascular tone, liver and kidney health, and overall cardiometabolic risk.

Low values usually reflect lower uric acid and/or higher HDL-C, indicating lower oxidative load, adequate renal urate excretion, and more effective HDL transport. System-wide this aligns with better insulin sensitivity and endothelial function. Children and early pregnancy are typically lower.

Being in range suggests balanced purine production, renal handling, and HDL-mediated lipid traffic, supporting metabolic stability and control of low-grade inflammation. No universal cutoffs exist; in studies, lower-to-mid ratios track with favorable risk.

High values usually reflect higher uric acid and/or lower HDL-C. Physiology includes increased purine turnover, reduced renal urate clearance, and insulin resistance with fewer or less functional HDL particles. This pattern is linked to endothelial dysfunction, a tendency toward hypertension, fatty liver, kidney strain, cardiometabolic disease, and higher gout risk when urate is elevated. Men and postmenopausal women often run higher; late pregnancy and preeclampsia can raise it.

Notes: Fasting state, hydration, acute illness, and medications influence interpretation. Thiazide/loop diuretics and low-dose aspirin raise urate; niacin raises urate and HDL; SGLT2 inhibitors lower urate. HDL assay methods vary. There are no standardized decision thresholds, so compare with lab references and follow trends over time.